NCT06940804View on ClinicalTrials.gov

A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2025

Primary Completion Date

June 30, 2042

Study Completion Date

June 30, 2042

Conditions
Testicular Germ Cell TumorExtragonadal Germ Cell Tumor
Interventions
BIOLOGICAL

CLDN6 CAR-T

Intravenous (IV) infusion

BIOLOGICAL

CLDN6 RNA-LPX

IV injection

Sponsors

Lead Sponsor

BioNTech SE
All Listed Sponsors
lead

BioNTech SE

INDUSTRY